abstract |
A composition for administration into the nasal cavity, the rectal cavity and the vaginal cavity, wherein the composition is an essentially non-aqueous composition comprising: not less than 25% by weight of one or more cannabinoid(s); from 25% to 55% by weight one or more phospholipid(s); and optionally one or more antioxidant(s). |